Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-03-2021 | Thoracic Pain | Brief Report

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients

Authors: M. Karolyi, E. Pawelka, S. Omid, H. Kelani, T. Mader, S. Baumgartner, H. Laferl, M. Traugott, T. Seitz, A. Zoufaly, C. Wenisch

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2021

Abstract

SARS-CoV-2 infection is associated with increased risk of thrombosis in severely ill patients but little is known about the risk in outpatients with mild to moderate disease. Our case series consists of four male otherwise healthy patients between 32 and 50 years of age. Initial symptoms completely resolved but they developed new onset of dyspnea and thoracic pain at days 14 to 26. CT scan revealed pulmonary embolism in all patients which led to hospitalization. Standard anticoagulation practice needs to be re-evaluated and may be considered for certain outpatients with COVID-19.

Wu C, Chen X, MD, Cai Y, et al. (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia inWuhan, China. JAMA Intern Med. doi:10.1001/jamainternmed.2020.0994

Zhou F, Yu T, Du R, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. Published Online March 9, 2020 https://doi.org/10.1016/S0140-6736(20)30566-3

Tang N, Li D, Wang X et al (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18:844–847CrossRef

Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. https://doi.org/10.1111/jth.14817

Han H, Yang L, Liu R et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-0188

Cui S, Chen S, Li X et al (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. https://doi.org/10.1111/JTH.14830

Vaduganathan M, Vardeny O, Michel T et al (2020) Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. NEJM. https://doi.org/10.1056/NEJMsr2005760

Celi A, Cianchetti S, Dell'Omo G, Pedrinelli R (2010 Dec) Angiotensin II, tissue factor and the thrombotic paradox of hypertension. Expert Rev Cardiovasc Ther. 8(12):1723–1729. https://doi.org/10.1586/erc.10.161CrossRefPubMed

Skurk T, Lee YM, Hauner H (2001 May) Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension. 37(5):1336–1340CrossRef

10.

Liu Y, Yang Y, Zhang C et al (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 63:364–374. https://doi.org/10.1007/s11427-020-1643-8CrossRefPubMedPubMedCentral

11.

Dunham-Snary K, Wu D, Sykes E et al. (2017) Hypoxic pulmonary vasoconstriction. Chest; 151(1): 181–192. Published online 2016 Sep 16. doi: 10.1016/j.chest.2016.09.001

Title: Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
Authors: M. Karolyi
E. Pawelka
S. Omid
H. Kelani
T. Mader
S. Baumgartner
H. Laferl
M. Traugott
T. Seitz
A. Zoufaly
C. Wenisch
Publication date: 01-03-2021
Publisher: Springer Berlin Heidelberg
Keywords: Thoracic Pain
Dyspnea
SARS-CoV-2
Dyspnea
COVID-19
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-04044-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Positive virus detection in patients who recovered from COVID-19 during quarantine period between discharge and home: a two-center experience in Wuhan, China

The effect of oropharyngeal aspiration before position change on reducing the incidence of ventilator- associated pneumonia

Is it time to move away from polymyxins?: evidence and alternatives

Changes of intestinal microflora of breast cancer in premenopausal women

Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile

Multicenter study of automated systems for colistin susceptibility testing

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page